These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25317462)

  • 1. The lung microbiome in idiopathic pulmonary fibrosis. What does it mean and what should we do about it?
    Morris A; Gibson K; Collman RG
    Am J Respir Crit Care Med; 2014 Oct; 190(8):850-2. PubMed ID: 25317462
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.
    Molyneaux PL; Cox MJ; Wells AU; Kim HC; Ji W; Cookson WO; Moffatt MF; Kim DS; Maher TM
    Respir Res; 2017 Feb; 18(1):29. PubMed ID: 28143484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.
    Molyneaux PL; Cox MJ; Willis-Owen SA; Mallia P; Russell KE; Russell AM; Murphy E; Johnston SL; Schwartz DA; Wells AU; Cookson WO; Maher TM; Moffatt MF
    Am J Respir Crit Care Med; 2014 Oct; 190(8):906-13. PubMed ID: 25184687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.
    O'Dwyer DN; Ashley SL; Gurczynski SJ; Xia M; Wilke C; Falkowski NR; Norman KC; Arnold KB; Huffnagle GB; Salisbury ML; Han MK; Flaherty KR; White ES; Martinez FJ; Erb-Downward JR; Murray S; Moore BB; Dickson RP
    Am J Respir Crit Care Med; 2019 May; 199(9):1127-1138. PubMed ID: 30789747
    [No Abstract]   [Full Text] [Related]  

  • 5. The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.
    Knudsen KS; Lehmann S; Nielsen R; Tangedal S; Haaland I; Hiemstra PS; Eagan TM
    PLoS One; 2022; 17(1):e0262082. PubMed ID: 34990493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients.
    Tong X; Su F; Xu X; Xu H; Yang T; Xu Q; Dai H; Huang K; Zou L; Zhang W; Pei S; Xiao F; Li Y; Wang C
    Front Cell Infect Microbiol; 2019; 9():149. PubMed ID: 31165050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis.
    Kitsios GD; Rojas M; Kass DJ; Fitch A; Sembrat JC; Qin S; Veraldi KL; Gibson KF; Lindell K; Pilewski JM; Methe B; Li K; McDyer J; McVerry BJ; Morris A
    Thorax; 2018 May; 73(5):481-484. PubMed ID: 28802277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.
    Molyneaux PL; Willis-Owen SAG; Cox MJ; James P; Cowman S; Loebinger M; Blanchard A; Edwards LM; Stock C; Daccord C; Renzoni EA; Wells AU; Moffatt MF; Cookson WOC; Maher TM
    Am J Respir Crit Care Med; 2017 Jun; 195(12):1640-1650. PubMed ID: 28085486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies.
    Fastrès A; Felice F; Roels E; Moermans C; Corhay JL; Bureau F; Louis R; Clercx C; Guiot J
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases.
    Amati F; Stainer A; Mantero M; Gramegna A; Simonetta E; Suigo G; Voza A; Nambiar AM; Cariboni U; Oldham J; Molyneaux PL; Spagnolo P; Blasi F; Aliberti S
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.
    Han MK; Zhou Y; Murray S; Tayob N; Noth I; Lama VN; Moore BB; White ES; Flaherty KR; Huffnagle GB; Martinez FJ;
    Lancet Respir Med; 2014 Jul; 2(7):548-56. PubMed ID: 24767767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis.
    Huang Y; Ma SF; Espindola MS; Vij R; Oldham JM; Huffnagle GB; Erb-Downward JR; Flaherty KR; Moore BB; White ES; Zhou T; Li J; Lussier YA; Han MK; Kaminski N; Garcia JGN; Hogaboam CM; Martinez FJ; Noth I;
    Am J Respir Crit Care Med; 2017 Jul; 196(2):208-219. PubMed ID: 28157391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary infection in Wegener granulomatosis and idiopathic pulmonary fibrosis.
    Richter AG; Stockley RA; Harper L; Thickett DR
    Thorax; 2009 Aug; 64(8):692-7. PubMed ID: 19359270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Antibiotics, Airway Microbiome, and Inflammation in Infants with Cystic Fibrosis.
    Pittman JE; Wylie KM; Akers K; Storch GA; Hatch J; Quante J; Frayman KB; Clarke N; Davis M; Stick SM; Hall GL; Montgomery G; Ranganathan S; Davis SD; Ferkol TW;
    Ann Am Thorac Soc; 2017 Oct; 14(10):1548-1555. PubMed ID: 28708417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory microbiome in IPF: cause, effect, or biomarker?
    Molyneaux PL; Maher TM
    Lancet Respir Med; 2014 Jul; 2(7):511-3. PubMed ID: 24767768
    [No Abstract]   [Full Text] [Related]  

  • 16. The microbiome in IPF: tissue is not the issue.
    Molyneaux PL
    Thorax; 2021 Mar; 76(3):218. PubMed ID: 33593961
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiographic Honeycombing and Altered Lung Microbiota in Patients with Idiopathic Pulmonary Fibrosis.
    Dickson RP; Huffnagle GB; Flaherty KR; White ES; Martinez FJ; Erb-Downward JR; Moore BB; O'Dwyer DN
    Am J Respir Crit Care Med; 2019 Dec; 200(12):1544-1547. PubMed ID: 31419390
    [No Abstract]   [Full Text] [Related]  

  • 18. Utility of Conventional Culture and MALDI-TOF MS for Identification of Microbial Communities in Bronchoalveolar Lavage Fluid in Comparison with the GS Junior Next Generation Sequencing System.
    Sung JY; Hwang Y; Shin MH; Park MS; Lee SH; Yong D; Lee K
    Ann Lab Med; 2018 Mar; 38(2):110-118. PubMed ID: 29214754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent Legionnaires' Disease and Associated Antibiotic Treatment Engender a Highly Disturbed Pulmonary Microbiome Enriched in Opportunistic Microorganisms.
    Pérez-Cobas AE; Ginevra C; Rusniok C; Jarraud S; Buchrieser C
    mBio; 2020 May; 11(3):. PubMed ID: 32430469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of bronchoalveolar lavage to assess the respiratory microbiome: signal in the noise.
    Twigg HL; Morris A; Ghedin E; Curtis JL; Huffnagle GB; Crothers K; Campbell TB; Flores SC; Fontenot AP; Beck JM; Huang L; Lynch S; Knox KS; Weinstock G;
    Lancet Respir Med; 2013 Jul; 1(5):354-6. PubMed ID: 24429191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.